GlassScriptPhysician profile
Ravinder S Kahlon
NPI 1548695547
$10,015.90
in general payments reported to CMS, 2019-2025
30 companies · $1,227 in 2025
The $1,227 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $83.73 · 2021: $708 · 2022: $4,888 · 2023: $412 · 2024: $2,587 · 2025: $1,227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,626 · Consulting Fee: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,626.18 |
| Consulting Fee | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $3,600.00 | 2022 | |
| Kestra Medical Technology Services, INC. | $1,528.95 | 2024-2025 | Assure Wcd |
| Edwards Lifesciences Corporation | $894.70 | 2021-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Medtronic, INC. | $887.74 | 2021-2024 | Corevalve Evolut R |
| Abbott Laboratories | $867.77 | 2021-2024 | Cardiomems |
| Novartis Pharmaceuticals Corporation | $247.91 | 2021-2025 | |
| Boston Scientific Corporation | $236.68 | 2021-2023 | Varithena Administration Pack |
| W. L. Gore & Associates, INC. | $219.66 | 2021 | |
| Abiomed | $213.57 | 2022-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $201.02 | 2023-2024 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $170.25 | 2022-2025 | Lifevest |
| Atricure, INC. | $160.86 | 2024 | |
| Amgen INC. | $150.39 | 2022-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $132.61 | 2019-2025 | Lokelma, Farxiga |
| Shockwave Medical, INC | $83.73 | 2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $51.18 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $47.49 | 2023-2024 | Xarelto |
| Novo Nordisk INC | $42.79 | 2023 | Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.52 | 2022-2024 | Jardiance |
| Cvrx, INC. | $38.19 | 2024 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $27.45 | 2023 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $26.25 | 2023 | Uptravi, Opsumit |
| Sanofi-Aventis U.S. LLC | $22.64 | 2023 | |
| Chiesi USA, INC. | $22.41 | 2024 | Juxtapid |
| Philips North America LLC | $22.35 | 2024 | (Ck4) Mcot |
| Ekos Corporation | $21.87 | 2019 | |
| Bridgebio Pharma, INC. | $17.78 | 2025 | Attruby |
| Takeda Pharmaceuticals U.S.A., INC. | $14.88 | 2024 | Hyqvia |
| Ethicon US, LLC | $14.69 | 2024 | Stratafix, Dermabond Prineo, Ethicon |
| Itamar Medical INC | $10.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravinder Kahlon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.